| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Western Amyotrophic Lateral Sclerosis Group.
Using 42 strength and functional assessments recorded monthly, the natural history of amyotrophic lateral sclerosis (ALS) is described in 167 patients (98 men, 67 women) followed in five medical centers in the western United States. The mean age at onset was 57.4 years, and symptoms were present for 2.64 years before study entry. Although there was a highly variable rate of decline within the group of patients, there were no differences in rate of decline by age or gender. Older patients and women were weaker on entry. Forty-eight patients died during the study. The median survival was 4.0 years for the study cohort but 2.1 years for newly diagnosed cases. Decline in pulmonary function most closely correlated with death. Our results emphasize the importance of considering clinical variability in planning clinical trials. One possible strategy is to identify and stratify patients by rate of decline in pulmonary function since prospectively identifying homogeneous subgroups allows investigators to substantially reduce sample size in therapeutic trials.
Address correspondence and reprint requests to Dr. Steven P. Ringel, University of Colorado Health Sciences Center, 4200 E. Ninth Avenue, B185, Denver, CO 80262.
Supported by a grant from the Muscular Dystrophy Association, Inc.
Received August 17, 1992. Accepted for publication in final form December 1,1992.
*Deceased
This article has been cited by other articles:
|
|
 |
|
  W. -K. Kim, X. Liu, J. Sandner, M. Pasmantier, J. Andrews, L. P. Rowland, and H. Mitsumoto Study of 962 patients indicates progressive muscular atrophy is a form of ALS Neurology, November 17, 2009; 73(20): 1686 - 1692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Zoccolella, E Beghi, G Palagano, A Fraddosio, V Guerra, V Samarelli, V Lepore, I L Simone, P Lamberti, L Serlenga, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 33 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Czaplinski, L. J. Haverkamp, A. A. Yen, E. P. Simpson, E. C. Lai, and S. H. Appel The value of database controls in pilot or futility studies in ALS Neurology, November 28, 2006; 67(10): 1827 - 1832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Levy, P. Kaufmann, R. Buchsbaum, J. Montes, A. Barsdorf, R. Arbing, V. Battista, X. Zhou, H. Mitsumoto, B. Levin, et al. A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS Neurology, March 14, 2006; 66(5): 660 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Czaplinski, A A Yen, and S H Appel Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 390 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Morgan, S. McNally, M. Alexander, R. Conroy, O. Hardiman, and R. W. Costello Use of Sniff Nasal-Inspiratory Force to Predict Survival in Amyotrophic Lateral Sclerosis Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 269 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Carter, M. D. Weiss, J.-S. Lou, M. P. Jensen, R. T. Abresch, T. K. Martin, T. W. Hecht, J. J. Han, P. Weydt, and G. H. Kraft Modafinil to treat fatigue in amyotrophic lateral sclerosis: An open label pilot study American Journal of Hospice and Palliative Medicine, January 1, 2005; 22(1): 55 - 59. [Abstract] [PDF]
|
|
|
|
 |
|
 W.D-C. Man, J. Moxham, and M.I. Polkey Magnetic stimulation for the measurement of respiratory and skeletal muscle function Eur. Respir. J., November 1, 2004; 24(5): 846 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Amtmann, P. Weydt, K. L. Johnson, M. P. Jensen, and G. T. Carter Survey of cannabis use in patients with amyotrophic lateral sclerosis American Journal of Hospice and Palliative Medicine, March 1, 2004; 21(2): 95 - 104. [Abstract] [PDF]
|
|
|
|
|
|
M.A. del Aguila, W.T. Longstreth Jr, V. McGuire, T.D. Koepsell, and G. van Belle Prognosis in amyotrophic lateral sclerosis: A population-based study Neurology, March 11, 2003; 60(5): 813 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R S Howard and R W Orrell Management of motor neurone disease Postgrad. Med. J., December 1, 2002; 78(926): 736 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Talbot Motor neurone disease Postgrad. Med. J., September 1, 2002; 78(923): 513 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M D Bradley, R W Orrell, J Clarke, A C Davidson, A J Williams, D M Kullmann, N Hirsch, and R S Howard Outcome of ventilatory support for acute respiratory failure in motor neurone disease J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 752 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.B. Chaudri, C. Liu, R. Hubbard, D. Jefferson, and W.J. Kinnear Relationship between supramaximal flow during cough and mortality in motor neurone disease Eur. Respir. J., March 1, 2002; 19(3): 434 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Lyall, N. Donaldson, M. I. Polkey, P. N. Leigh, and J. Moxham Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis Brain, October 1, 2001; 124(10): 2000 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hadjikoutis and C.M. Wiles Venous serum chloride and bicarbonate measurements in the evaluation of respiratory function in motor neuron disease QJM, September 1, 2001; 94(9): 491 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Varrato, A. Siderowf, P. Damiano, S. Gregory, D. Feinberg, and L. McCluskey Postural change of forced vital capacity predicts some respiratory symptoms in ALS Neurology, July 24, 2001; 57(2): 357 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Ansevin Treatment of ALS with pleconaril Neurology, March 13, 2001; 56(5): 691 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Miller, F. A. Anderson Jr., W. G. Bradley, B. R. Brooks, H. Mitsumoto, T. L. Munsat, and S. P. Ringel The ALS Patient Care Database: Goals, design, and early results Neurology, January 11, 2000; 54(1): 53 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Desport, P. M. Preux, T. C. Truong, J. M. Vallat, D. Sautereau, and P. Couratier Nutritional status is a prognostic factor for survival in ALS patients Neurology, September 1, 1999; 53(5): 1059 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ganzini, W. S. Johnston, and W. F. Hoffman Correlates of suffering in amyotrophic lateral sclerosis Neurology, April 1, 1999; 52(7): 1434 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ganzini, W. S. Johnston, B. H. McFarland, S. W. Tolle, and M. A. Lee Attitudes of Patients with Amyotrophic Lateral Sclerosis and Their Care Givers toward Assisted Suicide N. Engl. J. Med., October 1, 1998; 339(14): 967 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Bryan, J. S. Reisch, G. McDonald, L. L. Herbelin, R. J. Barohn, and J. L. Fleckenstein Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis Neurology, July 1, 1998; 51(1): 110 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. MONDELLI, P. D. PORTA, A. ZALAFFI, and A. ROSSI Carpal Tunnel Syndrome in Amyotrophic Lateral Sclerosis and Late Onset Cerebellar Ataxia J Hand Surg Eur Vol., August 1, 1996; 21(4): 553 - 558. [Abstract] [PDF]
|
|
|
|
 |
|
 The ALS CNTF Treatment Study (ACTS) Phase I-II Stu The Amyotrophic Lateral Sclerosis Functional Rating Scale: Assessment of Activities of Daily Living in Patients With Amyotrophic Lateral Sclerosis Arch Neurol, February 1, 1996; 53(2): 141 - 147. [Abstract] [PDF]
|
|
|
|
|
|
P. McKee, G. N. Fuller, D. L. Stevens, K. D. MacRae, R. S. Burgerman, M. A. Rogawski, J. R. Murphy, G. Bensimon, L. Lacomblez, V. Meininger, et al. Riluzole in Amyotrophic Lateral Sclerosis N. Engl. J. Med., July 28, 1994; 331(4): 272 - 274. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
